AU2021422913A1 - Apparatus and systems for monitoring and treating cataracts - Google Patents
Apparatus and systems for monitoring and treating cataracts Download PDFInfo
- Publication number
- AU2021422913A1 AU2021422913A1 AU2021422913A AU2021422913A AU2021422913A1 AU 2021422913 A1 AU2021422913 A1 AU 2021422913A1 AU 2021422913 A AU2021422913 A AU 2021422913A AU 2021422913 A AU2021422913 A AU 2021422913A AU 2021422913 A1 AU2021422913 A1 AU 2021422913A1
- Authority
- AU
- Australia
- Prior art keywords
- cataracts
- light
- treating
- monitoring
- light source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002177 Cataract Diseases 0.000 title claims abstract description 174
- 238000012544 monitoring process Methods 0.000 title claims abstract description 130
- 230000003287 optical effect Effects 0.000 claims abstract description 37
- 238000011282 treatment Methods 0.000 claims description 46
- 230000003595 spectral effect Effects 0.000 claims description 12
- 238000011896 sensitive detection Methods 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 6
- 238000013500 data storage Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 210000000695 crystalline len Anatomy 0.000 description 79
- 210000001508 eye Anatomy 0.000 description 43
- 238000002189 fluorescence spectrum Methods 0.000 description 22
- 230000008901 benefit Effects 0.000 description 21
- 230000005284 excitation Effects 0.000 description 15
- 238000001356 surgical procedure Methods 0.000 description 13
- 238000000034 method Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 210000001525 retina Anatomy 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- 238000004061 bleaching Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 206010036346 Posterior capsule opacification Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- 206010038848 Retinal detachment Diseases 0.000 description 2
- 206010057430 Retinal injury Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010014801 endophthalmitis Diseases 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000004264 retinal detachment Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000003164 Diplopia Diseases 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010047555 Visual field defect Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000029444 double vision Diseases 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/13—Ophthalmic microscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0008—Apparatus for testing the eyes; Instruments for examining the eyes provided with illuminating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/117—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes
- A61B3/1173—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes for examining the eye lens
- A61B3/1176—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes for examining the eye lens for determining lens opacity, e.g. cataract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/13—Ophthalmic microscopes
- A61B3/135—Slit-lamp microscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/0079—Methods or devices for eye surgery using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0627—Dose monitoring systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0632—Constructional aspects of the apparatus
- A61N2005/0633—Arrangements for lifting or hinging the frame which supports the light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
- A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0665—Reflectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0665—Reflectors
- A61N2005/0666—Reflectors for redirecting light to the treatment area
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0667—Filters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Electromagnetism (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Cash Registers Or Receiving Machines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2101007.9A GB2603006B (en) | 2021-01-26 | 2021-01-26 | Apparatus and systems for monitoring and treating cataracts |
GB2101007.9 | 2021-01-26 | ||
PCT/EP2021/064249 WO2022161647A1 (en) | 2021-01-26 | 2021-05-27 | Apparatus and systems for monitoring and treating cataracts |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021422913A1 true AU2021422913A1 (en) | 2023-09-07 |
Family
ID=79248985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021422913A Pending AU2021422913A1 (en) | 2021-01-26 | 2021-05-27 | Apparatus and systems for monitoring and treating cataracts |
Country Status (4)
Country | Link |
---|---|
US (1) | US20240090763A1 (zh) |
EP (1) | EP4284230A1 (zh) |
CN (1) | CN113924143A (zh) |
AU (1) | AU2021422913A1 (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5550909B2 (ja) * | 2006-11-10 | 2014-07-16 | ラーセン, ラース マイケル | 眼の非破壊的或いは低破壊的光操作のための方法及び装置 |
EP2420179B1 (en) * | 2010-08-16 | 2020-10-07 | Cognoptix, Inc. | System and method for detecting amyloid proteins |
US9521949B2 (en) * | 2011-06-23 | 2016-12-20 | Amo Development, Llc | Ophthalmic range finding |
GB201522555D0 (en) * | 2015-12-21 | 2016-02-03 | Edinburgh Biosciences Ltd | Eye treatment system |
CN108743020A (zh) * | 2018-06-28 | 2018-11-06 | 百锐明医疗科技(北京)有限公司 | 眼科激光治疗设备 |
-
2021
- 2021-05-27 US US18/263,088 patent/US20240090763A1/en active Pending
- 2021-05-27 EP EP21731407.9A patent/EP4284230A1/en active Pending
- 2021-05-27 CN CN202180002521.9A patent/CN113924143A/zh active Pending
- 2021-05-27 AU AU2021422913A patent/AU2021422913A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4284230A1 (en) | 2023-12-06 |
US20240090763A1 (en) | 2024-03-21 |
CN113924143A (zh) | 2022-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5227811B2 (ja) | 眼科機器 | |
CA2263262C (en) | Method and system for measurement of macular carotenoid levels | |
KR101471579B1 (ko) | 눈의 비파괴성 또는 최소 파괴성 광처리 장치 | |
US8123353B2 (en) | Ophthalmologic apparatus and method for the observation, examination, diagnosis, and/or treatment of an eye | |
JP3850192B2 (ja) | 眼底撮影装置 | |
KR101061004B1 (ko) | 광역학 치료 및 광 검출을 위한 장치 | |
US11202918B2 (en) | Eye treatment system | |
JPS59225057A (ja) | 治療用光線としてのレ−ザ−光線を用いて眼底で光凝固する際に線量を測定する方法及び装置 | |
WO2016160820A1 (en) | Method and apparatus for concurrent imaging at visible and infrared wavelengths | |
JPH1014857A (ja) | 蛍光観察による悪性組織の診断装置及び診断法 | |
JP2009148568A (ja) | 蛍光画像の分析処理方法 | |
US4852987A (en) | Device for measuring eye lens opacity | |
EP1011416B1 (en) | Apparatus for measuring the autofluorescence of the cornea of an eye | |
US20240090763A1 (en) | Apparatus and systems for monitoring and treating cataracts | |
WO2022161647A1 (en) | Apparatus and systems for monitoring and treating cataracts | |
US11779211B2 (en) | Fluorescein fluorescent fundus angiography device employing polarizing beam splitter and linear polarizing filter | |
JP2004113322A (ja) | 眼科用治療装置 | |
Zuclich | In-vivo measurements of optical properties of the ocular lens | |
CN114173664A (zh) | 用于对介质执行光致发光分析的系统和方法 | |
RU2651126C1 (ru) | Способ раннего выявления возрастной макулярной дистрофии сетчатки | |
CN114813678A (zh) | 一种测量玻璃材料自发荧光的设备及方法 | |
Atif | Study of the spectral features of different biological samples | |
Docchio et al. | Design and performance of a new fluorometer for corneal autofluorescence measurement |